MYCN and neuroblastoma: However, as this review will point out, the discovery of novel, MYCN-interacting proteins overexpressed in neuroblastoma, such as Aurora kinase A, provide exciting opportunities for pharmacological strategies aimed at downregulating MYCN independent of its transcriptional function.